Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net loss	$ (4,631,655)	$ (2,678,062)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	6,675	5,355
Amortization of intangibles	52,365	23,380
Stock based compensation	853,548	1,005,273
Employees paid in stock	293,551	264,953
Expense paid in stock	201,251	372,901
Bad Debt	8,525
Amortization of right-of-use asset	76,330	72,149
Changes in operating assets and liabilities:
Increase in accounts receivable	(240,073)	(238,305)
Increase in accounts receivable, related parties	(9,612)	(3,013)
Increase in inventories	(413,773)	(1,073,450)
(Increase) decrease in advances on contracts	(139,442)	360,242
Decrease (increase) prepaid expenses and other current assets	58,071	(128,345)
Increase in accounts payable	991,474	448,461
Increase in accounts payable, related party	534,047	329,504
Decrease in accrued expenses	(616,426)	(243,999)
Increase in accrued expenses, related party	358,477	144,758
Decrease operating right of use lease asset	(73,831)	(70,189)
Net cash used in operating activities	(2,690,498)	(1,408,387)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	(12,008)	(6,596)
Sale of marketable securities		2,976,573
Net cash used in provided by investing activities	(12,008)	2,969,977
Cash flows from financing activities:
Net proceeds from public placement offering		192,156
Proceeds from issuances of convertible notes, related parties	800,000
Net Proceeds exercise of warrants		51,751
Payments finance lease obligations	(10,251)	(7,613)
Net cash provided by financing activities	789,749	236,294
Net (decrease) increase in cash and cash equivalents	(1,912,757)	1,797,884
Cash and cash equivalents at beginning of period	3,258,058	2,977,713
Cash and cash equivalents at end of period	$ 1,345,301	$ 4,775,597